BELLUSCURA PLC LS -01
Belluscura plc develops and commercialize oxygen related medical device products in the United States. The company offers X-PLOR and DISCOV-R, a modular portable oxygen concentrator; and related accessories. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.
Market Cap & Net Worth: BELLUSCURA PLC LS -01 (9VQ)
BELLUSCURA PLC LS -01 (F:9VQ) has a market capitalization of $3.30 Million (€3.21 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #36111 globally and #4374 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BELLUSCURA PLC LS -01's stock price €0.01 by its total outstanding shares 401309607 (401.31 Million).
BELLUSCURA PLC LS -01 Market Cap History: 2021 to 2025
BELLUSCURA PLC LS -01's market capitalization history from 2021 to 2025. Data shows change from $519.04 Million to $3.30 Million (-65.76% CAGR).
BELLUSCURA PLC LS -01 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BELLUSCURA PLC LS -01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 9VQ by Market Capitalization
Companies near BELLUSCURA PLC LS -01 in the global market cap rankings as of March 19, 2026.
Key companies related to BELLUSCURA PLC LS -01 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
BELLUSCURA PLC LS -01 Historical Marketcap From 2021 to 2025
Between 2021 and today, BELLUSCURA PLC LS -01's market cap moved from $519.04 Million to $ 3.30 Million, with a yearly change of -65.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €3.30 Million | -92.00% |
| 2024 | €41.19 Million | -56.14% |
| 2023 | €93.92 Million | -68.98% |
| 2022 | €302.77 Million | -41.67% |
| 2021 | €519.04 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of BELLUSCURA PLC LS -01 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.30 Million USD |
| MoneyControl | $3.30 Million USD |
| MarketWatch | $3.30 Million USD |
| marketcap.company | $3.30 Million USD |
| Reuters | $3.30 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.